These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 23822091)
1. The unique N-terminal region of SRMS regulates enzymatic activity and phosphorylation of its novel substrate docking protein 1. Goel RK; Miah S; Black K; Kalra N; Dai C; Lukong KE FEBS J; 2013 Sep; 280(18):4539-59. PubMed ID: 23822091 [TBL] [Abstract][Full Text] [Related]
2. Phosphoproteomics Analysis Identifies Novel Candidate Substrates of the Nonreceptor Tyrosine Kinase, Goel RK; Paczkowska M; Reimand J; Napper S; Lukong KE Mol Cell Proteomics; 2018 May; 17(5):925-947. PubMed ID: 29496907 [TBL] [Abstract][Full Text] [Related]
3. Understanding the cellular roles of Fyn-related kinase (FRK): implications in cancer biology. Goel RK; Lukong KE Cancer Metastasis Rev; 2016 Jun; 35(2):179-99. PubMed ID: 27067725 [TBL] [Abstract][Full Text] [Related]
4. Structure, Function, and Regulation of the SRMS Tyrosine Kinase. McClendon CJ; Miller WT Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32545875 [TBL] [Abstract][Full Text] [Related]
5. Role of the Brk SH3 domain in substrate recognition. Qiu H; Miller WT Oncogene; 2004 Mar; 23(12):2216-23. PubMed ID: 14676834 [TBL] [Abstract][Full Text] [Related]
6. Src protein-tyrosine kinase structure and regulation. Roskoski R Biochem Biophys Res Commun; 2004 Nov; 324(4):1155-64. PubMed ID: 15504335 [TBL] [Abstract][Full Text] [Related]
7. Palmitylation of Src family tyrosine kinases regulates functional interaction with a B cell substrate. Saouaf SJ; Wolven A; Resh MD; Bolen JB Biochem Biophys Res Commun; 1997 May; 234(2):325-9. PubMed ID: 9177269 [TBL] [Abstract][Full Text] [Related]
8. A nuclear export signal and phosphorylation regulate Dok1 subcellular localization and functions. Niu Y; Roy F; Saltel F; Andrieu-Soler C; Dong W; Chantegrel AL; Accardi R; Thépot A; Foiselle N; Tommasino M; Jurdic P; Sylla BS Mol Cell Biol; 2006 Jun; 26(11):4288-301. PubMed ID: 16705178 [TBL] [Abstract][Full Text] [Related]
9. Protein-tyrosine Phosphatase and Kinase Specificity in Regulation of SRC and Breast Tumor Kinase. Fan G; Aleem S; Yang M; Miller WT; Tonks NK J Biol Chem; 2015 Jun; 290(26):15934-47. PubMed ID: 25897081 [TBL] [Abstract][Full Text] [Related]
10. Activation of Src family kinases in Neu-induced mammary tumors correlates with their association with distinct sets of tyrosine phosphorylated proteins in vivo. Muthuswamy SK; Muller WJ Oncogene; 1995 Nov; 11(9):1801-10. PubMed ID: 7478608 [TBL] [Abstract][Full Text] [Related]
11. Phosphatidylinositol 3-kinase and Src family kinases are required for phosphorylation and membrane recruitment of Dok-1 in c-Kit signaling. Liang X; Wisniewski D; Strife A; Shivakrupa ; Clarkson B; Resh MD J Biol Chem; 2002 Apr; 277(16):13732-8. PubMed ID: 11825908 [TBL] [Abstract][Full Text] [Related]
12. Seeking a better understanding of the non-receptor tyrosine kinase, SRMS. Goel RK; Kim N; Lukong KE Heliyon; 2023 Jun; 9(6):e16421. PubMed ID: 37251450 [TBL] [Abstract][Full Text] [Related]
13. PH006, a novel and selective Src kinase inhibitor, suppresses human breast cancer growth and metastasis in vitro and in vivo. Ma JG; Huang H; Chen SM; Chen Y; Xin XL; Lin LP; Ding J; Liu H; Meng LH Breast Cancer Res Treat; 2011 Nov; 130(1):85-96. PubMed ID: 21181437 [TBL] [Abstract][Full Text] [Related]
14. A novel adaptor-like protein which is a substrate for the non-receptor tyrosine kinase, BRK. Mitchell PJ; Sara EA; Crompton MR Oncogene; 2000 Aug; 19(37):4273-82. PubMed ID: 10980601 [TBL] [Abstract][Full Text] [Related]
15. Fyn is a downstream target of the pleiotrophin/receptor protein tyrosine phosphatase beta/zeta-signaling pathway: regulation of tyrosine phosphorylation of Fyn by pleiotrophin. Pariser H; Ezquerra L; Herradon G; Perez-Pinera P; Deuel TF Biochem Biophys Res Commun; 2005 Jul; 332(3):664-9. PubMed ID: 15925565 [TBL] [Abstract][Full Text] [Related]
16. Expression of the SNT-1/FRS2 phosphotyrosine binding domain inhibits activation of MAP kinase and PI3-kinase pathways and antiestrogen resistant growth induced by FGF-1 in human breast carcinoma cells. Manuvakhova M; Thottassery JV; Hays S; Qu Z; Rentz SS; Westbrook L; Kern FG Oncogene; 2006 Sep; 25(44):6003-14. PubMed ID: 16682955 [TBL] [Abstract][Full Text] [Related]
17. Tyrosine phosphorylation profiling reveals the signaling network characteristics of Basal breast cancer cells. Hochgräfe F; Zhang L; O'Toole SA; Browne BC; Pinese M; Porta Cubas A; Lehrbach GM; Croucher DR; Rickwood D; Boulghourjian A; Shearer R; Nair R; Swarbrick A; Faratian D; Mullen P; Harrison DJ; Biankin AV; Sutherland RL; Raftery MJ; Daly RJ Cancer Res; 2010 Nov; 70(22):9391-401. PubMed ID: 20861192 [TBL] [Abstract][Full Text] [Related]
18. Activation of the focal adhesion kinase signaling pathway by structural alterations in the carboxyl-terminal region of c-Crk II. Zvara A; Fajardo JE; Escalante M; Cotton G; Muir T; Kirsch KH; Birge RB Oncogene; 2001 Feb; 20(8):951-61. PubMed ID: 11314030 [TBL] [Abstract][Full Text] [Related]
19. Protein kinase G type Ialpha activity in human ovarian cancer cells significantly contributes to enhanced Src activation and DNA synthesis/cell proliferation. Leung EL; Wong JC; Johlfs MG; Tsang BK; Fiscus RR Mol Cancer Res; 2010 Apr; 8(4):578-91. PubMed ID: 20371672 [TBL] [Abstract][Full Text] [Related]
20. Fyn membrane localization is necessary to induce the constitutive tyrosine phosphorylation of Sam68 in the nucleus of T lymphocytes. Lang V; Semichon M; Michel F; Brossard C; Gary-Gouy H; Bismuth G J Immunol; 1999 Jun; 162(12):7224-32. PubMed ID: 10358169 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]